EPTIFIBATIDE ring scaffold, identified as a convergent dual KPC-3/MSH3 hit via Vina docking and Nash synergy analysis, may interfere with Ebola VP40 matrix protein oligomerisation by occupying the hydrophobic pocket at the VP40 N-terminal domain dimer interface.
Adversarial Debate Score
38% survival rate under critique
Model Critiques
Supporting Research Papers
- Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products
The Ebola virus (EBOV) is a lethal pathogen causing hemorrhagic fever syndrome which remains a global health challenge. In the EBOV, two multifunctional proteins, VP35 and VP40, have significant roles...
- Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules
Ebola virus (EBOV) causes hemorrhagic fever in humans with high morbidity and fatality. Although over 45 years have passed since the first EBOV outbreak, small molecule drugs are not yet available. Eb...
- Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies
- Identification of potential inhibitors targeting Ebola virus VP35 protein: a computational strategy
Abstract Ebola virus (EBOV) poses a severe threat as a highly infectious pathogen, causing devastating hemorrhagic fever in both humans and animals. The EBOV virus VP35 protein plays a crucial role in...
- Ginkgolic acid Inhibits Ebola Virus Transcription and Replication by Disrupting the Interaction Between Nucleoprotein and VP30 Protein.
The Ebola virus, a filovirus, has been responsible for significant human fatalities since its discovery. Despite extensive research, effective small-molecule drugs remain elusive due to its complex pa...
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.